BAP1 deficiency inflames the tumor immune microenvironment and is a candidate biomarker for immunotherapy response in malignant pleural mesothelioma
Article in JTO Clinical and Research Reports (May 2024)
The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.
Article in JTO Clinical and Research Reports (May 2024)
Article in Annual Review of Pathology Mechanisms of Disease (September 2023)
Article in Virchows Archiv (July 2023)